Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-04
2007-12-04
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S319000, C514S617000, C546S205000, C544S400000, C564S161000
Reexamination Certificate
active
10949841
ABSTRACT:
The present invention relates to compounds capable of serving as moderators of human and mammalian appetite and as such provides a means for reducing body mass. The compounds of the present invention are selective against melanin concentrating hormone and do not have the pernicious side effects resulting from compounds which interact with other appetite related brain receptors.
REFERENCES:
patent: 6310107 (2001-10-01), Kato et al.
patent: 6472394 (2002-10-01), McKittrick et al.
patent: 6930185 (2005-08-01), Ishihara et al.
patent: 2004/0077628 (2004-04-01), Ishirara et al.
patent: 4438029 (1996-05-01), None
patent: 19614718 (1997-10-01), None
patent: 0430459 (1991-06-01), None
patent: 0 540 051 (1993-05-01), None
patent: WO 94/18204 (1994-08-01), None
patent: WO 94/27597 (1994-12-01), None
patent: WO 95/32967 (1995-12-01), None
patent: WO 96/30333 (1996-10-01), None
patent: WO 98/38156 (1998-09-01), None
patent: WO 01/21577 (2001-03-01), None
patent: WO 01/087834 (2001-11-01), None
patent: WO 02/051809 (2002-07-01), None
patent: WO 02/076947 (2002-10-01), None
patent: WO 03/028641 (2003-04-01), None
patent: WO 03/035055 (2003-05-01), None
patent: WO 03/045313 (2003-06-01), None
patent: WO 03/045918 (2003-06-01), None
patent: WO 03/045920 (2003-06-01), None
patent: WO 03/047568 (2003-06-01), None
patent: WO 2004/024702 (2004-03-01), None
patent: WO 2004/037777 (2004-05-01), None
patent: WO 2004/092116 (2004-10-01), None
Meyers, K., et al., Novel Pyrazolopiperazinone- and Pyrrolopiperazinone-based MCH-R1 Antagonists, Bioorganic & Medicinal Chemistry Letters 17 (2007) 657-661.
Buhlmayer, P. et al., “Nonpeptidic Angiotensin II Antagonists: Synthesis and In Vitro Activity of a Series of Novel Naphthalene and Tetrahydronapthalene Derivatives”,J. Med. Chem., 1991, vol. 34, pp. 3105-3114.
Nakayama, T. et al., “Synthesis and Structure-Activity Study of Protease Inhibitors. II. Amino- and Guanidino-substituted Naphthoates and Tetrahydronaphthoates”, Chem. Abstract No. XP002319488, (Database Caplus on line; Accession No. 1985: 112993, abstract.).
Kobayashi, S. et al., “Preparation of sulfonyl moiety-containing heterocyclic compounds as factor Xa inhibitors”, Chem. Abstract No. XP002319489, (Database Caplus on line; Accession No. 2000: 133658 (abstract).
Clay Cynthia L.
Leeser Erich
McDow Kelly L.
Paul Andrew A.
The Procter & Gamble & Company
LandOfFree
Melanin concentrating hormone antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanin concentrating hormone antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanin concentrating hormone antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3826549